Chatbots are now prescribing psychiatric drugs

Curated RSS Brief

Chatbots are now prescribing psychiatric drugs

Published: April 03, 2026 at 11:43 | Source: theverge.com

Quick Summary

AI Close AI Posts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All AI Science Close Science Posts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All Science Tech Close Tech Posts from this topic will be added to your daily email digest and your homepage feed. Follow Follow See All Tech Chatbots are now prescribing psychiatric drugs Some psychiatrists are asking what problem, exactly, this is solving. Some psychiatrists are asking what problem, exactly, this is solving. by Robert Hart Close Robert Hart AI Reporter Posts from this author will be added to your daily email digest and your homepage feed. Follow Follow See All by Robert Hart Apr 3, 2026, 11:43 AM UTC Link Share Gift Image: Cath Virginia / The Verge Robert Hart Close Robert Hart Posts from this author will be added to your daily email digest and your homepage feed. Follow Follow See All by Robert Hart is a London-based reporter at The Verge covering all things AI and a Senior Tarbell Fellow. Previously, he wrote about health, science and tech for Forbes . Utah is allowing an AI system to prescribe psychiatric drugs without a doctor. It's only the second time the state — and the country — has delegated this kind of clinical authority to AI. State officials say it could bring costs down and ease care shortages, but physicians warn the system is opaque, risky, and unlikely to expand mental health care to those who need it. The one-year pilot, announced last week , will allow Legion Health's AI chatbot to renew certain prescriptions for psychiatric medications, in some cases. The San Francisco startup promises Utah-based patients "fast, simple refills" through a $19-a-month subscription. The program starts at some point in April, though the company is only operating a waitlist at the moment. The AI chatbot will renew certain prescriptions for psychiatric medications, in some cases. The program is deliberately narrow in scope, limited both in terms of the medications it covers and the conditions patients must meet to qualify. According to Legion's agreement with Utah's Office of Artificial Intelligence Policy, the chatbot can renew only 15 lower-risk maintenance medications that have already been prescribed by a clinician. That includes fluoxetine (Prozac), sertraline (Zoloft), bupropion (Wellbutrin), mirtazapine, and hydroxyzine, commonly used to treat anxiety and depression. Patients must also be considered stable: Anyone with a recent dose or medication change or a psychiatric hospitalization in the last year is excluded, and patients must check in with a healthcare provider every 10 refills or after six months, whichever comes first. Related It's not easy to get depression-detecting AI through the FDA Giving your healthcare info to a chatbot is, unsurprisingly, a terrible idea Chatbots are struggling with suicide hotline numbers The system cannot issue new prescriptions or handle medications that require closer clinical oversight, including drugs that need blood-test monitoring. Controlled substances are also barred, ruling out many ADHD medications. The exclusion of benzodiazepines, used for anxiety; antipsychotics, used for conditions like schizophrenia and bipolar disorder; and lithium — widely considered the gold-standard treatment for bipolar disorder — leaves many more complex psychiatric cases outside the pilot's scope. To use the system, patients must opt-in, verify their identity, and prove they already have a prescription, such as by providing a photo of the label or pill bottle. They are then asked about their symptoms, as well as side effects and efficacy of the medication. They're asked questions about suicidal thoughts, self-harm, severe reactions, and pregnancy in order to log red flags. If any answers fall outside of the pilot's low-risk criteria, the cases are supposed to be escalated to a clinician before any refill is issued. Patients and pharmacists can also request human review. "By safely automating the renewal process for maintenance medications, we are allowing patients to get the care they need much more quickly and affordably," state officials said when announcing the pilot. Over time, they said, the program could free healthcare providers to "focus their time on more complex, higher-risk patient needs" and help address shortages that have left 500,000 Utah residents without access to mental health care. Legion cofounder and CEO Yash Patel has cast the program in even grander terms, describing it as a global first that will dramatically expand access to healthcare and mark "the beginning of something much bigger than refills." Psychiatrists are less convinced. Brent Kious, a psychiatrist and professor at the University of Utah School of Medicine, told The Verge he thinks the "advantages of an AI-based refill system may be overstated." He suspects the tool "will not increase access for those who are most in need of care

Key Takeaways

• AI Close AI Posts from this topic will be added to your daily email digest and your homepage feed.
• Follow Follow See All AI Science Close Science Posts from this topic will be added to your daily email digest and your homepage feed.
• Follow Follow See All Science Tech Close Tech Posts from this topic will be added to your daily email digest and your homepage feed.
• Follow Follow See All Tech Chatbots are now prescribing psychiatric drugs Some psychiatrists are asking what problem, exactly, this is solving.

Detailed Coverage

Market analysis reveals significant growth potential in the sector discussed in 'Chatbots are now prescribing psychiatric drugs'. Investment patterns and market trends indicate strong confidence in these technologies, with venture capital and corporate investments driving further innovation and development.

User experience and accessibility are key themes that emerge from the analysis of 'Chatbots are now prescribing psychiatric drugs'. The focus on creating intuitive, user-friendly interfaces demonstrates a commitment to making advanced technology accessible to broader audiences and diverse user groups.

The competitive landscape highlighted in 'Chatbots are now prescribing psychiatric drugs' shows how different organizations are positioning themselves in this rapidly evolving market. Strategic partnerships, acquisitions, and research collaborations are shaping the future direction of technological development.

Environmental sustainability and energy efficiency considerations are increasingly important in the context of 'Chatbots are now prescribing psychiatric drugs'. The industry is moving towards more sustainable practices and green technologies to address climate change and environmental concerns.

Education and skill development play crucial roles in the adoption and advancement of technologies discussed in 'Chatbots are now prescribing psychiatric drugs'. The need for specialized talent and continuous learning programs highlights the importance of human capital in technological progress.

Article Details

Published: April 03, 2026 at 11:43

Source: theverge.com

Original link: https://www.theverge.com/ai-artificial-intelligence/906525/ai-chatbot-prescribe-refill-psychiatric-drugs

Read the Full Article

If you want the exact wording, examples, or full context from the publisher, open the original source article.

Open Original Article

This article email was generated from your RSS automation workflow.

Blog home: https://rkoots.github.io/blog/